EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Revolutionizing Heart Failure Management With Artificial Intelligence: A Narrative Review of Diagnostic, Prognostic, and Therapeutic Innovations

Revolutionierung des Managements der Herzinsuffizienz mit künstlicher Intelligenz: narrative Übersicht zu diagnostischen, prognostischen und therapeutischen Innovationen

Farrukh Ansar iD, Muhammad Aamir Waheed iD, Usman Zafar, Abdulrahman Kolapo, Walid Sarfaraz, Khalid Rashid

Health Science Reports · 2026-04 · 9 (4)

DOI: 10.1002/hsr2.71855 ↗

Auf einen Blick

Die narrative Übersicht beschreibt KI-Anwendungen in der Herzinsuffizienzversorgung. Berichtet werden diagnostische Modelle, automatisierte Bildauswertung und Monitoring mit teils hoher Genauigkeit.

Fragestellung

Welche klinisch validierten KI-Anwendungen gibt es entlang der Herzinsuffizienzversorgung?

Methode

Narrative Übersicht aktueller peer-reviewter Studien zu KI-gestützten Tools in ECG, Echokardiographie, CMR, Fernmonitoring und Smart Devices.

Ergebnisse

KI-ECG-Modelle erreichten für linksventrikuläre systolische Dysfunktion und diastolische Beeinträchtigung AUC-Werte bis 0,92. EchoGo, PanEcho, HeartLogic und CardioMEMS wurden als Beispiele genannt.

Einschränkungen

Herausforderungen bei Datenvielfalt, Modelltransparenz und klinischer Integration.

Schlussfolgerung der Autor:innen

KI-Technologien verändern die Herzinsuffizienzversorgung durch frühere Diagnostik, individualisierte Therapie und proaktives Monitoring.

Kernaussagen

  • KI-ECG-Modelle: AUC bis 0,92
  • Bildgebende KI automatisiert Ejektionsfraktion und diastolische Funktion
  • Wearables/Sensoren können Dekompensation Tage vor klinischer Verschlechterung vorhersagen

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Health Science Reports, published online on 2026-03-30. Written by Farrukh Ansar and 5 co-authors. Institution: Alkhidmat Raazi Hospital Islamabad Pakistan. Cited 1 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Hamad Medical Corporation.

Auf einen BlickAbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Aims Heart failure (HF) remains a major global health burden, affecting over 64 million individuals worldwide. Early detection and optimal management are often limited by subjective interpretation of diagnostic tests and variable clinical expertise. Artificial intelligence (AI) has emerged as a transformative technology that can enhance diagnostic precision, risk stratification, and therapeutic decision‐making. This review aims to synthesize current evidence on clinically validated AI applications across the HF care continuum.

Methods

A narrative review of recent peer‐reviewed studies was conducted to evaluate AI‐based tools applied in electrocardiography (ECG), echocardiography, cardiac magnetic resonance (CMR), remote monitoring, and smart devices. Emphasis was placed on studies reporting validated performance metrics such as area under the curve (AUC), sensitivity, and specificity, and those integrated into clinical workflows or approved by regulatory bodies.

Results

AI‐enhanced ECG models have demonstrated high diagnostic accuracy for left‐ventricular systolic dysfunction and diastolic impairment, with AUC values up to 0.92; surpassing traditional risk scores. In cardiac imaging, deep‐learning systems now automate ejection‐fraction and diastolic‐function quantification with precision comparable to expert readers. AI‐driven platforms such as EchoGo and PanEcho enable efficient and consistent image interpretation, while wearables and implantable sensors like HeartLogic and CardioMEMS provide real‐time hemodynamic monitoring and predict decompensation several days before clinical deterioration (sensitivity 70%–88%). Over 40 AI‐based cardiovascular tools have received regulatory clearance, supporting their translational maturity.

Conclusion

AI technologies are redefining HF care by enabling earlier diagnosis, individualized therapy, and proactive monitoring. However, challenges persist regarding data diversity, model transparency, and clinical integration.

Authors and institutions

  • Alkhidmat Raazi Hospital Islamabad Pakistan.
  • Hamad General Hospital/Qatar University Doha Qatar.
  • Lincoln County Hospital Lincoln UK.
  • North Cumbria Integrated Care NHS Trust UK.
  • University Hospital North Tees and Hartpool NHS Trust UK.

ORCID profiles: Farrukh Ansar, Muhammad Aamir Waheed

Funding

  • Hamad Medical Corporation

Cite

APA

Ansar, F., Waheed, M. A., Zafar, U., Kolapo, A., Sarfaraz, W., & Rashid, K. (2026). Revolutionizing Heart Failure Management With Artificial Intelligence: A Narrative Review of Diagnostic, Prognostic, and Therapeutic Innovations. Health Science Reports, 9(4). https://doi.org/10.1002/hsr2.71855

Vancouver

Ansar F, Waheed MA, Zafar U, Kolapo A, Sarfaraz W, Rashid K. Revolutionizing Heart Failure Management With Artificial Intelligence: A Narrative Review of Diagnostic, Prognostic, and Therapeutic Innovations. Health Science Reports. 2026;9(4). doi:10.1002/hsr2.71855

BibTeX
@article{Ansar2026,
  author = {Ansar, Farrukh and Waheed, Muhammad Aamir and Zafar, Usman and Kolapo, Abdulrahman and Sarfaraz, Walid and Rashid, Khalid},
  title = {Revolutionizing Heart Failure Management With Artificial Intelligence: A Narrative Review of Diagnostic, Prognostic, and Therapeutic Innovations},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.1002/hsr2.71855}
}
Start for free →